Log in to your Inderes Free account to see all free content on this page.
QUIA PHARMA
0.00 SEK
Less than 1K followers
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
0.00 %
-66.67 %
-73.68 %
-82.76 %
-88.28 %
-93.49 %
-99.98 %
-100.00 %
-100.00 %
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Read moreMarket cap
1.97M SEK
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2.
2026
Annual report '25
All
Press releases
ShowingAll content types
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio